Related references
Note: Only part of the references are listed.BDNF as a Promising Therapeutic Agent in Parkinson's Disease
Ewelina Palasz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The Role of Mitochondria in Inflammation: From Cancer to Neurodegenerative Disorders
Sonia Missiroli et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
Leonardo Guzman-Martinez et al.
FRONTIERS IN PHARMACOLOGY (2019)
Mitochondrial dysfunction increases pro-inflammatory cytokine production and impairs repair and corticosteroid responsiveness in lung epithelium
R. F. Hoffmann et al.
SCIENTIFIC REPORTS (2019)
Time-course behavioral features are correlated with Parkinson's disease-associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model
Rui-Jun Su et al.
MOLECULAR MEDICINE REPORTS (2018)
Protective role of chrysin on 6-hydroxydopamine-induced neurodegeneration a mouse model of Parkinson's disease: Involvement of neuroinflammation and neurotrophins
Andre T. R. Goes et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Inflammation in CNS neurodegenerative diseases
Jodie Stephenson et al.
IMMUNOLOGY (2018)
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease
Kuo-Hsuan Chang et al.
MOLECULAR NEUROBIOLOGY (2018)
Naringenin protects against oxido-inflammatory aberrations and altered tryptophan metabolism in olfactory bulbectomized-mice model of depression
Yashika Bansal et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease
Sandra Franco-Iborra et al.
FRONTIERS IN NEUROSCIENCE (2018)
Linking Neuroinflammation and Neurodegeneration in Parkinson's Disease
Geraldine Gelders et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Neuroprotection against 6-OHDA toxicity in PC12 cells and mice through the Nrf2 pathway by a sesquiterpenoid from Tussilago farfara
Joohee Lee et al.
REDOX BIOLOGY (2018)
Involvement of BDNF/TrkB signaling in the effect of diphenyl diselenide on motor function in a Parkinson's disease rat model
Tuane Bazanella Sampaio et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
Mimicking Parkinson's Disease in a Dish: Merits and Pitfalls of the Most Commonly used Dopaminergic In Vitro Models
Fernanda Martins Lopes et al.
NEUROMOLECULAR MEDICINE (2017)
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases
Michael D. Lovelace et al.
NEUROPHARMACOLOGY (2017)
TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson's disease
Seong Su Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Berberine protects against 6-OHDA-induced neurotoxicity in PC12 cells and zebrafish through hormetic mechanisms involving PI3K/AKT/Bcl-2 and Nrf2/HO-1 pathways
Chao Zhang et al.
REDOX BIOLOGY (2017)
Discovery of IDO1 Inhibitors: From Bench to Bedside
George C. Prendergast et al.
CANCER RESEARCH (2017)
Mitochondrial DNA Depletion in Respiratory Chain-Deficient Parkinson Disease Neurons
Anne Gruenewald et al.
ANNALS OF NEUROLOGY (2016)
Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals
Sarah M. Clark et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2016)
Parkinson's Disease: The Mitochondria-Iron Link
Yorka Munoz et al.
PARKINSONS DISEASE (2016)
Expression of Tgfβ1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease
Stefan Jean-Pierre Haas et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2016)
Niflumic acid, a TRPV1 channel modulator, ameliorates stavudine-induced neuropathic pain
Lovish Marwaha et al.
INFLAMMOPHARMACOLOGY (2016)
Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model
O. Ozsoy et al.
FREE RADICAL RESEARCH (2015)
A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson's disease
Francesco Angelucci et al.
FRONTIERS IN HUMAN NEUROSCIENCE (2015)
Cerebral cortex, hippocampus, striatum and cerebellum show differential susceptibility to quinolinic acid-induced oxidative stress
Samuel Vandresen-Filho et al.
NEUROLOGICAL SCIENCES (2015)
A Simple High-Performance Liquid Chromatographic Method for the Simultaneous Determination of Monoamine Neurotransmitters and Relative Metabolites with Application in Mouse Brain Tissue
Christine Farthing et al.
JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES (2015)
Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease
Nancy G. Hernandez-Chan et al.
JOURNAL OF BIOMEDICAL SCIENCE (2015)
Inflammation in neurodegenerative diseases-an update
Sandra Amor et al.
IMMUNOLOGY (2014)
Activation of GSK-3β and Caspase-3 Occurs in Nigral Dopamine Neurons during the Development of Apoptosis Activated by a Striatal Injection of 6-Hydroxydopamine
Daniel Hernandez-Baltazar et al.
PLOS ONE (2013)
Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders
Denes Zadori et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2012)
ATP synthesis and storage
Massimo Bonora et al.
PURINERGIC SIGNALLING (2012)
Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease
Susan Duty et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Treating the Periphery to Ameliorate Neurodegenerative Diseases
Peter H. Reinhart et al.
CELL (2011)
Effects of pro-inflammatory cytokines on expression of kynurenine pathway enzymes in human dermal fibroblasts
Linnea Asp et al.
JOURNAL OF INFLAMMATION-LONDON (2011)
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
R. Lugo-Huitron et al.
NEUROTOXICOLOGY AND TERATOLOGY (2011)
The Involvement of Neuroinflammation and Kynurenine Pathway in Parkinson's Disease
Anna Zinger et al.
PARKINSONS DISEASE (2011)
Cytochrome c is rapidly reduced in the cytosol after mitochondrial outer membrane permeabilization
Maureen O. Ripple et al.
APOPTOSIS (2010)
Behavioral phenotyping of mouse models of Parkinson's disease
Tonya N. Taylor et al.
BEHAVIOURAL BRAIN RESEARCH (2010)
Mitochondrial dysfunction in Parkinson's disease
Konstanze F. Winklhofer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Fluorometric Determination of Quinolinic Acid Using the Catalytic Activity of Horseradish Peroxidase
Junichi Odo et al.
JOURNAL OF HEALTH SCIENCE (2009)
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats
Feng Jin et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets
Suparna A. Sarkar et al.
DIABETES (2007)
Indoleamine 2,3-dioxygenase (IDO) is involved in promoting the development of anterior chamber-associated immune deviation
Xuan Chen et al.
IMMUNOLOGY LETTERS (2006)
Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment
Chiara Rossi et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes
RG Tavares et al.
NEUROCHEMISTRY INTERNATIONAL (2002)
Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid
A Chiarugi et al.
JOURNAL OF NEUROCHEMISTRY (2001)